Concert Pharmaceuticals to Report Full Year 2019 Results on February 27, 2020
February 20 2020 - 7:00AM
Business Wire
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced
that it will report its financial results for the year ended
December 31, 2019, on Thursday, February 27, 2020, before the U.S.
financial markets open. The Company will host a conference call and
webcast at 8:30 a.m. ET to discuss 2019 financial results and
provide a business update. Individuals interested in participating
in the call should dial (855) 354-1855 (U.S. and Canada) or (484)
365-2865 (International).
A live webcast of the conference call may be accessed in the
Investors section of the Company’s website at
www.concertpharma.com. Please log on to the Concert website
approximately 15 minutes prior to the scheduled webcast to ensure
adequate time for any software downloads that may be required. A
replay of the webcast will be available on Concert’s website for
three months.
About Concert Concert Pharmaceuticals is a clinical stage
biopharmaceutical company focused on applying its DCE Platform®
(deuterated chemical entity platform) to create novel medicines
designed to treat serious diseases and address unmet patient needs.
The Company’s approach starts with previously studied compounds,
including approved drugs, in which deuterium substitution has the
potential to enhance clinical safety, tolerability or efficacy.
Concert’s pipeline of innovative medicines targets autoimmune
diseases and central nervous systems (CNS) disorders. For more
information please visit www.concertpharma.com or follow us on
Twitter at @ConcertPharma or on LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200220005041/en/
Justine Koenigsberg (781) 674-5284 ir@concertpharma.com
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Concert Pharmaceuticals (NASDAQ:CNCE)
Historical Stock Chart
From Oct 2023 to Oct 2024